Search - tctmd.com

Displaying 61 - 80 of 387

Sort: Relevancy | Date

News Daily News

New-Onset A-fib Following Noncardiac Surgery: Beware the Thromboembolic Risk

Yael L. Maxwell

October 16, 2018

News Daily News

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

Yael L. Maxwell

October 15, 2018

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

Todd Neale

October 12, 2018

News Daily News

Patients With A-fib and Cancer May Benefit From Visiting With a Cardiologist Early On

Todd Neale

October 10, 2018

News Daily News

GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm

Todd Neale

October 09, 2018

News Daily News

Risk Factors in Flux Increase CV Events and Death: More Evidence

Todd Neale

October 04, 2018

News Daily News

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Caitlin E. Cox

October 04, 2018

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

News Daily News

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

Todd Neale

October 03, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

News Daily News

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

Todd Neale

October 02, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

News Conference News TCT 2018

‘Telestenting’ an Early-Days but Enticing Idea for PCI’s Future

Lucy Hicks

September 27, 2018

News Conference News TCT 2018

Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch

Lucy Hicks

September 26, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Todd Neale

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr.

September 24, 2018

Presentation TCT 2018

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

Presenter: James B. Hermiller Jr, David Hildick-Smith, David E. Thaler

September 24, 2018

Presentation TCT 2018

A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC?

Presenter: Zahid Amin, Robert J. Sommer, Peter C. Block, John P. Breinholt, Craig E Fleishman, Jan Kovac, Harsimran Sachdeva Singh, Christian Spies

September 24, 2018

Advertisement

New-Onset A-fib Following Noncardiac Surgery: Beware the Thromboembolic Risk

Procedural Success Increasing for CTO PCI in Europe, Despite More Complex Lesions

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

Patients With A-fib and Cancer May Benefit From Visiting With a Cardiologist Early On

GALILEO Trial of Rivaroxaban After TAVR Stopped Early for Harm

Risk Factors in Flux Increase CV Events and Death: More Evidence

DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

‘Telestenting’ an Early-Days but Enticing Idea for PCI’s Future

Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content